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Abstract
Toll-like receptor 3 (TLR3) signaling has been implicated in neural stem/precursor cell (NPC) proliferation. However, the
molecular mechanisms involved, and their relationship to classical TLR-mediated innate immune pathways, remain
unknown. Here, we report investigation of the mechanics of TLR3 signaling in neurospheres comprised of epidermal growth
factor (EGF)-responsive NPC isolated from murine embryonic cerebral cortex of C57BL/6 (WT) or TLR3 deficient (TLR3
2/2)
mice. Our data indicate that the TLR3 ligand polyinosinic-polycytidylic acid (PIC) negatively regulates NPC proliferation by
inhibiting Sonic Hedgehog (Shh) signaling, that PIC induces apoptosis in association with inhibition of Ras-ERK signaling
and elevated expression of Fas, and that these effects are TLR3-dependent, suggesting convergent signaling between the
Shh and TLR3 pathways.
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Introduction
PIC is a synthetic analog of viral double-stranded (ds) RNA that
activates immune responses through two dsRNA sensors, TLR3
and melanoma differentiation-associated protein 5 (MDA5).
TLR3 senses PIC that has been internalized by endocytosis
[1,2]. Upon binding PIC, TLR3 signals through the adaptor
protein, Toll/IL-1 resistance domain-containing adaptor-inducing
IFN-b (TRIF). Interaction with the adaptor activates an array of
transcription factors, including IFN regulatory factor (IRF) 3,
IRF7, IRF1, and NFkB. These factors induce the expression of
genes encoding type I interferon (IFN, i.e., IFN-a and IFN-b) and
proinflammatory cytokines [3,4].
Recent evidence suggests that TLR3 plays a role in neural
development. TLR3 protein is present in mammalian brain cells in
early embryonic stages of development and serves as a negative
modulator of early embryonic NPC proliferation [5] and axonal
growth [6]. In a mouse model of prenatal virus infection, we
recently demonstrated that PIC-induced TLR3 activation inhibits
embryonic NPC proliferation and decreases the number of
neurons populating the upper layers of the cortex [7].
Single-cell suspensions of neural stem cells can be isolated from
the embryonic telencephalon and propagated in vitro as suspended,
spherical aggregates called neurospheres [8,9]. Epidermal growth
factor (EGF)-responsive NPC in neurospheres express the
neuroepithelial stem cell marker, nestin, and are derived from
rapidly-cycling, radial glia (RG) in the embryonic telencephalon.
Neural stem cells can give rise to all three major cell types of the
central nervous system: neurons, oligodendrocytes, and astrocytes
[10,11]. Accordingly, neurospheres contain a mixture of multip-
otent stem cells, proliferating precursor cells, postmitotic neurons
and glia [12,13,14]. Primary neurospheres can be clonally
passaged in vitro and provide a useful tool for analysis of the
proliferation and self-renewal capacity of neural stem and
precursor cells.
Regulation of the number of stem and precursor cells generated
during neural development is important for control of brain size
[15,16]. Shh signaling has been implicated in cell proliferation and
growth of embryonic and postnatal dorsal brain
[17,18,19,20,21,22,23]. Shh is a member of the hedgehog family
of secreted glycoproteins that binds the cell surface receptor
Patched (Ptch). Binding of Shh and related ligands to Ptch
abrogates its inhibition of the G-protein-coupled receptor,
Smoothened (Smo), resulting in increased expression of Gli1
zinc-finger transcription factors [24,25]. Three Gli proteins
participate in the mediation of Shh signaling: Gli1 and Gli2
function as transcription activators, whereas the truncated form of
Gli3, Gli3R, acts as a repressor [26,27,28,29]. Shh-Gli signaling
induces formation of Gli activators (Gli1, Gli2) that are imported
into the nucleus to transactivate target genes. Multiple effects of
Shh signaling on cyclin-dependent kinases (Cdks), Cdk inhibitors,
cyclins, N-myc or the transcription factor, E2F, acting at different
points of the cell cycle, may account for the proliferative effects of
Shh [30,31,32,33,34].
In mammals, Shh is the only hedgehog family member
expressed in the normal central nervous system [35]. Shh
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the embryonic telencephalon, Shh is expressed within the mantle
of the medial ganglionic eminence, the preoptic area and the
amygdala [35,36,37]. Shh secreted from differentiated cells in the
cortex can affect Gli1-positive, cycling precursor cells located at a
distance; in addition, Shh can also be produced by the precursors
themselves [18,38,39]. Genetic loss-of-function and knock-in
studies wherein Gli genes have been ablated and then reintro-
duced have shown that the Shh-Gli pathway controls the growth
and dorsal-ventral patterning of brain structures by regulating
proliferation of neural stem cells through EGF signaling
[40,41,42,43,44].
Shh signaling also plays a role in inducing apoptosis. Signaling
via Ptch, a 12–transmembrane domain receptor of Shh, induces
caspase-mediated apoptosis in neuroepithelial cells. The intracel-
lular domain of Ptch harbors a cleavage site for caspase 3; cleavage
at this site by caspase 3 exposes the proapoptotic domain of the
receptor. In vitro treatment of neuroepithelial cells with recombi-
nant Shh blocks Ptch-induced cell death [45,46].
Here we demonstrate that: (i) PIC negatively regulates NPC
proliferation by inhibiting Shh signaling, (ii) PIC induces apoptosis
in association with inhibition of Ras-ERK signaling and elevated
expression of Fas, and (iii) that these effects depend on TLR3
activation.
Results
Phenotypic analysis of EGF-responsive primary cortical
neurospheres
Neurospheres were generated from dissociated cerebral cortex
obtained from Wild-type (WT) or TLR3 knockout (TLR3
2/2)
C57BL/6 mouse embryos at GD14. The cellular composition of
neurospheres was surveyed by FACS after culture for 1 or 7 days
in proliferation medium supplemented with EGF (20 ng/ml).
After 1 day of culture, 65.2 6 1.8% of WT cells expressed GFAP,
a marker for astrocytes; 22.6 6 3.0% expressed tubulin-b-III, a
marker for young postmitotic neurons; 4.8 6 1.5% expressed
nestin, a marker for neuroepithelial stem cells (Fig. 1a; values
represent mean 6 SEM) [47,48,49]. After 7 days, the percentage
of GFAP
+ and tubulin-b-III
+ cells in WT neurospheres decreased
to 11.8 6 0.6% and 7.5% 6 1.2%, respectively, whereas the
percentage of nestin
+ precursors increased to 55.9 6 2.0%
(Fig. 1a; values represent mean 6 SEM). We observed similar
percentages of cells in day 7 neurosphere cultures derived from
TLR3 knockout mice (TLR3
2/2). After 7 days of culture,
63.062.0% of TLR3
2/2 neurosphere cells expressed nestin;
12.662.0% expressed GFAP; and 8.461.0% expressed tubulin-b-
III, suggesting that neurospheres derived from TLR3
2/2 mice are
equally responsive to EGF (Fig. 1a; values represent mean 6
SEM).
To further characterize the phenotype of nestin
+ NPC, day 7
WT and TLR3
2/2 neurosphere cells were analyzed by FACS for
expression of PAX6 and TBR2, two transcription factors
expressed in vivo by NPC during mid- and late cortical
neurogenesis [50,51,52]. 46.2 6 2.8% of WT and 62.3 6 2.0%
of TLR3
2/2 precursor cells co-expressed nestin and PAX6; 2.2 6
0.07% WT and 2.6 6 0.08% of TLR3
2/2 cells co-expressed
nestin and TBR2. PAX6 is a radial glial (RG) marker; thus, these
results indicate that the majority of the nestin
+ neurosphere-
derived cells in these dorsal telencephalon cultures are self-
renewing NPC (Fig. 1b; values represent mean 6 SEM).I nW T
neurosphere cells, intracellular expression of TLR3 was observed
(in nestin
+, PAX6
+, and TBR2
+ NPC populations (Fig. 1c).
The neurosphere culture model contains cells at various stages
of differentiation [8,9]. Whereas nestin-positive precursor cells are
typically located toward the outside of the sphere, GFAP-positive
cells are found in the center. Tubulin-b-III-positive neurons are
less common and tend to be evenly distributed [53]. In our
experiments, neurospheres were detected after one week of culture
of WT and TLR3
2/2 GD14 cortices (Fig. S1). The number of
nestin-positive cells was decreased by 50% in secondary versus
primary WT neurospheres (Fig. S2) and decreased continuously
with subsequent passages (data not shown) [54]. Thus, our
experiments were performed with primary neurospheres wherein
nestin expression was maximal. When dissociated and transferred
to differentiating conditions for 7 days, WT primary neurospheres
lost their spherical shape and flattened to form monolayers (Fig.
S3a). FACS analysis using cell lineage-specific antisera showed
that WT neurospheres were multipotent and capable of giving rise
to neurons, astrocytes, and oligodendrocytes. During differentia-
tion, WT cells expressed GFAP, tubulin-b-III, and O4, markers
characteristic for astrocytes, neurons and oligodendrocyte popu-
lations, respectively (Fig. S3b–f).
PIC negatively regulates neurosphere-derived NPC
proliferation in a TLR3-dependent manner
To assess the direct role of TLR3 signaling on NPC
proliferation, we used primary cortical neurosphere cultures
obtained from GD14 WT and TLR3-deficient (TLR3
2/2)
embryos. Neurospheres maintained in proliferation media for 7
days were treated with the TLR3 ligand, PIC (50 mg/ml), for
24 hours; BrdU was added for the final 12 hours of the culture.
Proliferative responses of neurosphere-derived cells were assessed
by flow cytometric measurement of labeled BrdU. Our results
indicate that BrdU was incorporated into the majority of nestin
+
cells, and that PIC exposure was associated with a reduced
percentage of BrdU
+nestin
+ precursor cells in WT neurosphere
cultures as compared to PBS-treated WT control cultures (n=12;
Mann-Whitney U, p=0.04; relative to PBS-treated WT control
group; Fig. 2a, b). PIC treatment resulted in a concomitant
increase in the percentage of BrdU-negative GFAP
+ and Tubulin-
b-III
+ subpopulations in the WT neurospheres (n=12; Mann-
Whitney U, p=0.04; relative to PBS-treated WT control group;
Fig. 2c, e). No significant differences were observed in expression
levels of GFAP and Tubulin-b-III markers in WT neurospheres
(n=12; Mann-Whitney U, p=0.29; Fig. 2d). Neurosphere
cultures derived from TLR3
2/2 mice were used to assess the
role of TLR3 signaling in the PIC-mediated inhibition of NPC
proliferation. No differences were observed in the percentage of
BrdU
+nestin
+ precursor cells in PIC-treated TLR3
2/2 neuro-
spheres as compared to PBS-treated TLR3
2/2 control cultures
(n=12; Mann-Whitney U, p=0.26; Fig. 2a, b). Taken together,
these results implicate TLR3 signaling in PIC-induced impairment
of proliferation of EGF-responsive NPC in cortical neurospheres.
PIC decreases neurosphere-derived neural precursor cell
proliferation by inhibiting Shh signaling
Shh signaling regulates the proliferation of EGF-responsive
precursor cells in the developing mouse neocortex [41]. To test
whether Shh signaling is active in the EGF-responsive precursor
cells found in neurospheres, we examined the expression of Shh
pathway receptors and targets in 7-day cultures from GD14
embryos. FACS analysis revealed that WT and TLR3
2/2 nestin
+
neurosphere cells expressed the membrane-associated Shh recep-
tor, Ptch (Fig. 3a). No change in the percentage of nestin
+ Ptch
+
cells was observed with PIC treatment. 11.0–15.0% of nestin
+ cells
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PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26766Figure 1. Phenotypic analysis of EGF-responsive primary cortical neurospheres. Primary neurospheres were obtained from cerebral cortex
cells isolated from WT and TLR3
2/2 embryos at GD14. Cell populations in neurospheres were assayed by using flow cytometry. (a) Percentages of
nestin-, GFAP- and Tubulin-b-III-expressing cells in neurospheres cultured for 24 hours or 7 days in proliferation medium supplemented with 20 ng/
ml of EGF. Three independent experiments were performed with neurosphere-derived cells isolated from WT and TLR3
2/2 embryos (n=12). Results
are expressed as percentages of total gated cells. Values represent mean 6 SEM. (b) Dot plots of PAX6, TBR2, and nestin expression in cells derived
from WT and TLR3
2/2 cortical neurospheres cultured for 7 days. Numbers in quadrants represent the percentages of each subpopulation. Three
independent cell culture assays were performed with cells isolated from WT and TLR3
2/2 embryos (n=12); data from one representative assay is
shown. (c) Dot plots of TLR3 expression in nestin
+, PAX6
+ and TBR2
+ WT cortical neurosphere cells cultured for 7 days. Numbers in quadrants
represent the percentages of each subpopulation. Three independent cell culture assays were performed with cells isolated from WT embryos
(n=12); data from one representative assay is shown.
doi:10.1371/journal.pone.0026766.g001
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WT and TLR3
2/2 Nestin
+ cells expressed the Shh-regulated
transcription factor, Gli1 (Fig. 3b, c). To test the effect of PIC on
Shh signaling in EGF-responsive NPC, GD14 WT and TLR3
2/2
cortical neurospheres were grown in EGF-supplemented medium
for 7 days, and treated with either PIC or PBS for the last 24 hours
of the culture period. FACS analysis of WT neurospheres
indicated that PIC treatment decreased the percentage of
Gli1
+nestin
+ cells (n=12; Mann-Whitney U, p=0.04; relative to
PBS-treated WT control group; Fig. 3b, d) and the mean
fluorescent intensity of Gli1 expression (n=12; Mann-Whitney U,
p=0.04; relative to PBS-treated WT control group; Fig. 3c). In
contrast, no differences were observed between TLR3
2/2 cells
treated with PIC or PBS (n=12; Mann-Whitney U, p=0.51;
relative to PBS-treated TLR3
2/2 control group; Fig. 3b–d).
Together, these results suggest that PIC-mediated inhibition of
Shh signaling in nestin
+ precursor cells may be occurring
downstream to Ptch and that this inhibition requires TLR3
expression.
Shh pathway activation reverses PIC-mediated inhibition
of neurosphere-derived NPC proliferation
Induction of Shh signaling with recombinant Shh protein
regulates proliferation of neural stem cells [41]. GD14 WT-
derived primary cortical neurospheres grown for 7 days in media
containing 5 ng/ml of EGF supplemented with 5 nM recombi-
Figure 2. PIC negatively regulates neurosphere-derived NPC proliferation in a TLR3-dependent manner. Proliferative response of
primary cortical neurospheres obtained from WT and TLR3
2/2 embryos at GD14. Neurospheres were maintained in EGF-containing (20 ng/ml)
medium for 7 days and treated with either PBS or PIC for 24 hours. BrdU was added for the last 12 hours of the culture. (a) Dot plots showing BrdU-
labeled nestin
+ cells in PBS- and PIC-treated neurospheres derived from WT and TLR3
2/2 mice. Numbers in quadrants represent the percentages of
each subpopulation. Three independent cell culture assays were performed with cells isolated from embryos (n=12); data from one representative
assay is shown. (b) Box plots showing percentages of BrdU
+nestin
+ cells in PBS- and PIC-treated neurospheres derived from WT and TLR3
2/2embryos.
Results are expressed as percentages of total cells (* p,0.05; relative to PBS control group; Mann-Whitney U test). (c) Histograms showing BrdU-
negative GFAP
+ and Tubulin-b-III
+ cells in PBS- and PIC-treated neurospheres derived from WT mice. Numbers in the graph represent the percentages
of each subpopulation. (d) Histograms showing the mean fluorescence intensity of GFAP and Tubulin-b-III expression in BrdU-negative cells from
PBS- and PIC-treated neurospheres obtained from WT mice. The mean fluorescence intensity is represented as a percentage of the maximum
expression: red line: PBS-treated cells; blue line: PIC-treated cells; and gray line: isotype control. (e) Box plots of the percentages of Tubulin-b-III
+BrdU
2
and GFAP
+BrdU
2 cells from PBS- and PIC-treated neurospheres derived from WT embryos. Results are expressed as percentages of total cells
(*, p,0.05; relative to PBS control group; Mann-Whitney U test). Height of box plots show interquartile range; horizontal line, median. Due to the low
numbers involved in the flow cytometry experiments, the box plot upper and lower interquartile ranges also represent the maximum and minimum
scores. White bars: PBS-treated mice, hatched bars: PIC-treated mice.
doi:10.1371/journal.pone.0026766.g002
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labeling (Fig. 4a). PIC treatment inhibited BrdU labeling in WT
neurospheres cultured in 5 ng/ml of EGF (n=12; Mann-Whitney
U, p=0.04; relative to PBS-treated WT control group; Fig. 4b,
d). Recombinant Shh treatment in the presence of 5 ng/ml of
EGF abrogated the PIC-mediated reduction in BrdU labeling
(n=12; Mann-Whitney U, p=0.52; relative to Shh and PBS-
treated WT control group; Fig. 4c, d). Under culture conditions
with a higher concentration of EGF (20 ng/ml) in the media, Shh
did not have this effect (data not shown), presumably because
stimuli for proliferation were already maximal [41]. These results
indicate that PIC-mediated inhibition of NPC proliferation can be
abrogated by stimulating the Shh pathway under culture
conditions wherein EGF concentration is sub maximal. To test
for direct evidence that PIC effect is due to Shh signaling
inhibition, neurosphere cultures were treated with cyclopamine, a
small molecule inhibitor of Shh signaling. Cyclopamine is a
steroidal alkaloid that specifically inhibits Shh pathway activation
by binding directly to the multipass transmembrane protein, Smo,
and regulating its function [55]. WT cortical neurospheres were
grown in 5 ng/ml of EGF supplemented with 5 mMo f
cyclopamine or ethanol (vehicle control group) for 7 days, and
treated with PIC or PBS for the last 24 hours of the culture period.
FACS analysis of WT neurospheres indicated that PIC treatment
in the presence of cyclopamine and EGF decreased the percentage
of Gli1
+nestin
+ cells when compared to PBS/ethanol-treated
vehicle control group (Fig. 5a). PIC treatment in the presence of
cyclopamine and EGF did not result in any additive effects in the
inhibition of Gli1 in comparison to cells that were treated with PIC
alone (Fig. 5a). These observations suggest: (i) a lack of synergy
between PIC and cyclopamine on Shh signaling, and (ii) in WT
neurosphere cells, PIC-mediated effects in the Shh signaling
pathway may be on effectors that are downstream to Ptch and
Smo. Furthermore, no differences in percentages of Gli1
+nestin
+
cells were observed in PIC-treated WT cells cultured in the
presence of recombinant Shh (5 nM) and EGF (5 ng/ml) in
Figure 3. PIC decreases neurosphere-derived NPC proliferation by inhibiting Shh signaling. Primary neurospheres were obtained from
cerebral cortex cells isolated from WT and TLR3
2/2 embryos at GD14. Neurospheres were cultured for 7 days in the presence of EGF (20 ng/ml) and
treated with either PBS or PIC for the last 24 hours of the culture period. (a) Representative histograms showing Patched expression in nestin-positive
cells from PBS- and PIC-treated neurospheres obtained from WT and TLR3
2/2 mice. Numbers in the graphs represent the percentage of nestin
+ cells
expressing Patched. Three independent cell culture assays were performed with cells isolated from embryos (n=12); data from one representative
assay is shown. (b) Dot plots showing Gli1
+nestin
+ cells in PBS- and PIC-treated neurospheres derived from WT and TLR3
2/2 mice. Numbers in
quadrants represent the percentages of each subpopulation. Three independent cell culture assays were performed with cells isolated from embryos
(n=12); data from one representative assay is shown. (c) Histograms showing the mean fluorescence intensity of Gli1 expression in PBS- and PIC-
treated neurospheres obtained from WT and TLR3
2/2 embryos. The mean fluorescence intensity is represented as a percentage of the maximum
expression: red line: PBS-treated cells, blue line: PIC-treated cells, and gray line: isotype control. (d) Box plot showing percentages of Gli1
+nestin
+ cells
in PBS- and PIC-treated neurospheres derived from WT and TLR3
2/2 embryos. Results are expressed as percentages of total cells (*, p,0.05 relative to
PBS control group; Mann-Whitney U test). Height of box plot shows interquartile range; horizontal line, median. Due to the low numbers involved in
the flow cytometry experiments, the box plot upper and lower interquartile ranges also represent the maximum and minimum scores. White bars:
PBS-treated mice, hatched bars: PIC-treated mice.
doi:10.1371/journal.pone.0026766.g003
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confirming our earlier observation that in neurosphere cultures, under
conditions of sub-maximal EGF stimulation, recombinant Shh
treatment abrogates the PIC-mediated effects on Shh signaling.
PIC induces apoptosis in primary cortical neurospheres
To test whether PIC altered viability of NPC, we measured
apoptosis in GD14 WT and TLR3
2/2 neurospheres after 7 days
of culture in proliferation medium supplemented with EGF
(20 ng/ml) that included 24 hours of treatment with PIC or
PBS. PIC resulted in a close to two-fold increase in the percentage
of annexin V
+ cells in WT neurospheres (n=12; Mann-Whitney
U, p=0.04; relative to PBS-treated WT control group; Fig. 6a,
c). In contrast, no significant differences were observed between
PIC- and PBS-treated TLR3
2/2 neurospheres (n=12; Mann-
Whitney U, p=0.27; relative to PBS-treated TLR3
2/2 control
group; Fig. 6b, c). These results indicate that PIC augments
apoptosis in NPC and that the effect is TLR3-dependent.
PIC prevents EGF/Shh-mediated ERK activation and
induces Fas expression in primary cortical neurospheres
To elucidate the molecular basis by which PIC mediates
inhibition of Shh pathway activation, we examined the effects of
PIC on the Ras-ERK pathway, a downstream effector of Shh and
EGFsignaling inGD14 WT primarycorticalneurospheres cultured
in the presence of EGF. PIC treatment decreased the percentage of
neurosphere-derived cells expressing phosphorylated-ERK, the
active form of the protein (n=12; Mann-Whitney U, p=0.02;
relative to PBS-treated WT control group; Fig. 7a, e). The mean
fluorescent intensity of phosphorylated-ERK was also reduced in
PIC-treated cells (n=12; Mann-Whitney U, p=0.04; relative to
PBS-treated WT control group; Fig. 7c). Consistent with studies
reporting regulation of Fas (CD95) expression via the Ras-ERK
pathway [56,57,58] Fas expression was elevated in WT cortical
NPC treated with PIC (n=12; Mann-Whitney U, p=0.02; relative
to PBS-treated WT controlgroup; Fig.7b, d, f). Collectively, these
results suggest that inhibition of Ras-ERK signaling by PIC may
lead to elevated levels of Fas and Fas-mediated apoptosis in NPC.
To elucidate that Poly IC-mediated effects are dependent on Shh,
neurosphere cultures were grown for 7 days in media supplemented
with recombinant Shh (5 nM) in the presence of sub-maximal
concentration of EGF (5 ng/ml) and treated with PIC or PBS as
described above. Recombinant Shh pre-treatment in the presence
of EGF abrogated PIC-mediated inhibition of phospho-ERK
expression in WT neurosphere cells as compared with PIC-treated
cells cultured in the presence of EGF alone (Fig. 8a, b).
Discussion
The majority of EGF-responsive nestin
+ cells in the cortical
neurosphere model correspond to the rapidly-cycling, PAX6
+ RG
stem cells and support the hypothesis that stem cells are contained
within the neuroepithelial-radial glia-astrocyte lineage [59]. We
recently reported that PAX6
+ RG cells express TLR3 in
Figure 4. Shh pathway activation reverses PIC-mediated
inhibition of neurosphere-derived NPC proliferation. Primary
neurospheres were obtained from cerebral cortex cells isolated from WT
embryos at GD14. Neurospheres were cultured for 7 days in the
presence of EGF (5 ng/ml) and treated with PBS or PIC for 24 hours.
BrdU was added for the last 12 hours of the culture. (a) Proliferative
response of neurospheres in EGF-containing medium with or without
added recombinant Shh protein (5 nM). Representative histograms
showing the mean fluorescence intensity of BrdU-labeled cells
represented as a percentage of maximum BrdU incorporation in WT
neurospheres: green line: EGF, red line: EGF + Shh, and gray line: isotype
control. (b) Representative histograms showing the mean fluorescence
intensity of BrdU labeling in PBS- or PIC-treated neurospheres cultured
in EGF. (c) Representative histograms showing the mean fluorescence
intensity of BrdU labeling in PBS- or PIC-treated neurospheres cultured
in the presence of EGF (5 ng/ml) and Shh (5 nM): red line: PBS-treated
cells, blue line: PIC-treated cells, and gray line: isotype control. (d) Box
plot showing the mean fluorescent intensity of BrdU-labeled cells in
PBS- and PIC-treated WT neurospheres cultured in the presence of EGF
and EGF + Shh. Results are expressed as percentages of maximum
expression (*, p,0.05 relative to PBS control group; Mann-Whitney U
test). Three independent cell culture assays were performed with cells
isolated from embryos (n=12). Height of box plot shows inter-quartile
range; horizontal line, median. Due to the low numbers involved in the
flow cytometry experiments, the box plot upper and lower interquartile
ranges also represent the maximum and minimum scores. White bars:
PBS-treated mice, hatched bars: PIC-treated mice.
doi:10.1371/journal.pone.0026766.g004
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that TLR3 receptors are expressed on NPC and regulate PIC
signaling. PIC treatment inhibited the proliferation of NPC and
increased the ratio of GFAP
+- and bIII-tubulin
+-differentiated
subpopulations in primary WT neurospheres. Although we
observed comparable NPC multipotency in control and PIC-
treated WT neurospheres (data not shown), we cannot ascertain
from current data whether PIC induces NPC differentiation.
The Ras-MEK-ERK signaling pathway is involved in cell
proliferation, apoptosis and differentiation. EGF stimulates cell
proliferation via the Ras-MEK-ERK signaling cascade [60,61,62].
Furthermore, Ras-ERK activation is implicated both in the
maintenance of tumor stem cells [63], and in regulation of Fas
transcription [56,64]. Our results in EGF-responsive NPC indicate
that Shh signaling machinery is present in nestin
+ NPC in primary
cortical neurospheres. PIC treatment inhibited Shh signaling in
WT primary neurospheres, resulting in reduced proliferation of
NPC. PIC also induced apoptosis in the WT neurospheres. In
Figure 9, we present a model of PIC-mediated effects on NPC.
PIC inhibits the Shh-mediated Ras-MEK-ERK signaling path-
way, resulting in reduced MEK (data not shown) and ERK
phosphorylation and increased Fas expression. Thus, PIC-
mediated inhibition of Ras-MEK-ERK activation may contribute
to both suppression of proliferation and induction of apoptosis.
PIC signals via a TLR3-dependent NFkB pathway to induce
IFN-a, IFN-b and proinflammatory cytokines [3,65]. Li and
colleagues have shown that IFN-a inhibits the Shh-activated Ras-
MEK-ERK pathway and induces apoptosis in human cancer cells
[46]. Our experiments with neurospheres from TLR3-deficient
mice indicate that PIC interferes with Shh signaling and NPC
proliferation in a TLR3-dependent manner: PIC treatment of
TLR3
2/2 neurospheres neither induced apoptosis nor decreased
proliferation. The factor(s) that mediate cross-talk between TLR3
and Shh signaling cascades are unknown. However, a recent study
describing Shh as a direct transcriptional target of NFkB [66]
suggests that the NFkB pathway may be pivotal.
Brain structures require Shh for normal proliferation and dorsal-
ventral patterning [67]. In humans, loss of Shh signaling causes
holoprosencephaly, a birth defect characterized by failure of
forebrain development [68,69]. Conversely, enhanced Shh signaling
has been implicated in cancers of prostate, pancreas, muscle and skin
as well as the brain [70,71]. In mice, development of the
telencephalon commences at GD11 and peaks between GD14 and
16; this time period is characterized by rapid expansion of NPC
Figure 5. Shh pathway activation reverses PIC-mediated inhibition of GLI1 expression in WT NPCs. Primary neurospheres were obtained
from cerebral cortex cells isolated from WT embryos at GD14. Neurospheres were cultured for 7 days with EGF (5 ng/ml) either in the presence or in
the absence of cyclopamine (5 mM) and treated with PIC for the last 24 hours. The control group includes cells cultured with EGF (5 ng/ml) and
ethanol and treated with PBS for the last 24 hours (vehicle control group) (a) Dot plots showing Gli1
+nestin
+ cells in PIC-treated WT neurospheres
cultured either in the presence or absence of cyclopamine and vehicle control group. Numbers in quadrants represent the percentages of each
subpopulation. Three independent cell culture assays were performed with cells isolated from embryos (n=12); data from one representative assay is
shown. (b) Dot plots showing Gli1
+nestin
+ cells expression in PBS- and PIC-treated neurospheres incubated in EGF-containing medium (5 ng/ml) with
or without added recombinant Shh protein (5 nM). Numbers in quadrants represent the percentages of each subpopulation. Three independent cell
culture assays were performed with cells isolated from embryos (n=12); data from one representative assay is shown.
doi:10.1371/journal.pone.0026766.g005
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During this critical period of central nervous system development,
aberrant TLR3 activation may have profound implications for NPC
proliferation, leading to deficits in telencephalon morphogenesis.
These findings provide a new mechanistic framework for under-
standing the pathogenesis of neurodevelopmental disorders associat-
ed with gestational and perinatal infections.
Materials and Methods
Mice
Ethics Statement. All mice were handled in accordance with
the Association for Assessment and Accreditation of Laboratory
Animals Care international guidelines, with the approval of the
Institutional Animal Care and Use Committee at Columbia
University under approval ID AC-AAAA4827. The Columbia
University IACUC reviewed and approved this study under ID
AC-AAAA4827.
Wild-type (WT) pregnant C57BL/6 mice at gestational day
(GD) 14 were obtained from Harlan Laboratories (Dublin, VA).
Congenic TLR3 deleted mice (TLR3
2/2) on a C57BL/6
background were obtained by repeated breeding of heterozygous
B6;129S1-Tlr
tm1 Flv/J TLR3 knockout mice (Jackson Laboratories,
Bar Harbor, ME) with WT C57BL/6 for ten generations.
Heterozygous mice, carrying the TLR3 deletion were identified
at each generation by PCR analysis of total genomic DNA using
the following primer sets: NEO_F CTTGGGTGGAGAGGC-
TATTC, NEO_R AGGTGAGATGACAGGAGATC, TLR3_F
Figure 6. PIC induces apoptosis in primary cortical neurospheres. Primary neurospheres were obtained from cerebral cortex cells isolated
from WT and TLR3
2/2 embryos at GD14. Neurospheres were cultured for 7 days in the presence of EGF (20 ng/ml) and treated with PBS or PIC for
24 hours. (a, b) Representative histograms showing Annexin V-positive cells in PBS- or PIC-treated WT or TLR3
2/2 neurospheres. Numbers in gates
represent the percentages of Annexin V
+ cells. Three independent cell culture assays were performed with cells isolated from embryos (n=12); data
from one representative assay is shown. (c) Box plot showing the percentages of Annexin V
+ cells in PBS- and PIC-treated neurospheres derived from
WT and TLR3
2/2 embryos. Results are expressed as percentages of total cells (*, p,0.05 relative to PBS control group; Mann-Whitney U test). Height
of box plot shows inter-quartile range; horizontal line, median. Due to the low numbers involved in the flow cytometry experiments, the box plot
upper and lower interquartile ranges also represent the maximum and minimum scores. White bars: PBS-treated mice, hatched bars: PIC-treated
mice.
doi:10.1371/journal.pone.0026766.g006
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neurospheres were obtained from cerebral cortex cells isolated from WT embryos at GD14. Neurospheres were cultured for 7 days in the presence of
EGF (20 ng/ml) and treated with PBS or PIC for 24 hours. (a, b) Representative histograms showing phospho-ERK and Fas-positive cells in PBS- or PIC-
treated WT neurospheres. Numbers in gates represent the percentages of phospho-ERK
+ and Fas
+ cells. Three independent cell culture assays were
performed with cells isolated from embryos (n=12); data from one representative assay is shown. (c, d) Representative histogram showing the mean
fluorescence intensity of phospho-ERK and Fas expression in PBS- and PIC-treated WT neurospheres. The mean fluorescence intensity is represented
as a percentage of the maximum expression, ——, PBS-treated cells; ——, PIC-treated cells; and ——, isotype control. (e, f) Box plots showing the
percentages of phospho-ERK
+ and Fas
+ cells in PBS- and PIC-treated neurospheres. Results are expressed as percentages of total cells (*, p,0.05
relative to PBS control group; Mann-Whitney U test). Height of box plots show interquartile range; horizontal line, median. Due to the low numbers
involved in the flow cytometry experiments, the box plot upper and lower interquartile ranges also represent the maximum and minimum scores.
White bars: PBS-treated mice, hatched bars: PIC-treated mice.
doi:10.1371/journal.pone.0026766.g007
Figure 8. Shh pathway activation reverses PIC-induced ERK activation. Primary neurospheres were obtained from cerebral cortex cells
isolated from WT embryos at GD14. Neurospheres were cultured for 7 days in the presence of EGF (5 ng/ml) and in the presence or absence of
recombinant Shh protein (5 nM), and treated with PBS or PIC for the last 24 hours of the culture. (a) Representative histograms showing percentage
of cells expressing phospho-ERK in WT neurospheres. Numbers in gates represent the percentages of phospho-ERK
+ cells. Three independent cell
culture assays were performed with cells isolated from embryos (n=12); data from one representative assay is shown. (b) Histogram showing the
mean fluorescence intensity of phospho-ERK expression in PBS- and PIC-treated WT neurospheres cultured in the presence or absence of
recombinant Shh. The mean fluorescence intensity is represented as a percentage of the maximum expression: red line: EGF and PBS-treated cells,
blue line: EGF and PIC-treated cells, green line: EGF + Shh and PIC-treated cells supplemented with Shh, and gray line: isotype control.
doi:10.1371/journal.pone.0026766.g008
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TTCGTGCAGAAGACAA. After 10 generations, heterozygous
mice were inter-crossed, and congenic homozygous TLR3
2/2
mice on a C57BL/6 background were selected to maintain the
colony. Time-pregnant TLR3
2/2 mice were obtained by selecting
vaginal plug positive (GD 0) dams from breeding pairs of
homozygous TLR3
2/2 mice.
Primary Neurosphere Cultures
Embryonic cortical neurosphere cultures were obtained using the
method of Reynolds and colleagues [8,9] with minor modifications.
Embryos were obtained from cesarean sections of GD14 pregnant
dams sacrificed under anesthesia. The embryos were sacrificed by
decapitation and the dorsal telencephalon was dissected, trimmed
and stripped of meninges in cold Hanks solution containing 5 mM
HEPES at pH.8.0, penicillin/streptomycin (Invitrogen, Carlsbad,
CA) and 0.8% D-glucose (Sigma-Aldrich, Saint Louis, MO, USA).
The tissue was then mechanically dissociated by gentle trituration
with fire-polished, glass Pasteur pipettes to yield single cell
suspensions. The cells were incubated to generate primary neuro-
spheres in NeuroCult NSC proliferation medium supplemented
with 20 ng/ml of human epidermal growth factor (EGF) and
Neurocult NSC proliferation supplements (StemCell Technologies,
Vancouver, BC, Canada). The cell suspensions were incubated at
37uC, 5% CO2 atmosphere in 10 ml at a concentration of 1610
5
cells/ml in T-25 tissue culture flasks and left undisturbed for 7 days
to generate neurospheres. For experiments with recombinant Shh
protein or cyclopamine, cells were cultured in NeuroCult NSC
proliferation media containing 5 ng/ml of EGF and supplemented
with either 56nM of recombinant human Shh (Invitrogen, San
Diego, CA) or 5 mM of cyclopamine (Toronto Research Chemicals
Inc., Ontario, Canada).
PIC treatment
Polyinosinic-polycytidylic potassium salt (Sigma Aldrich; St.
Louis, MO, USA) dissolved in PBS was heated to 55uC for 56min
Figure 9. PIC treatment inhibits the EGF-Shh-mediated Ras-ERK signaling pathway in primary cortical neurospheres. Shh binds to the
cell surface receptor Ptch, relieves the inhibition of Smo and triggers Shh signaling. Activation of the Shh pathway results in increased levels of Gli1
expression and activation of the downstream Ras-MEK-ERK pathway, causing cell proliferation. In WT neurospheres cultured in the presence of EGF,
PIC signals via TLR3 to inhibit Gli1 expression and interfere with MEK and ERK phosphorylation. Inhibition of MEK-ERK activation results in the
decreased proliferation and induced Fas expression and apoptosis observed after PIC treatment of primary cortical neurospheres.
doi:10.1371/journal.pone.0026766.g009
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was measured by UV spectroscopy [65]. Neurosphere cultures
maintained in proliferation medium for 7 days were treated with
50 mg/ml of PIC for the last 24 hours of the culture period. We
observed robust phenotypic changes in neurosphere cells that were
treated with 50 mg/ml of PIC without inducing significant loss of
viability; hence, all phenotypic testing was performed with cultures
treated with this dose of poly I:C..
Antibodies
Primary antibodies included: mouse anti-BrdU (1:50, Clone:
B44, Becton Dickinson, San Jose, CA), mouse anti-PAX6 (1:100,
developed by Atsushi Kawakami and obtained from Development
Studies Hybridoma Bank, University of Iowa, Iowa city, IA),
mouse anti-TBR2-PE (1:100, Clone: 21 Mgs8, eBioscience, San
Diego, CA), chicken anti-mouse serum TLR3 (1:500, Sigma-
Aldrich, St. Louis, MO), rat serum anti-mouse TLR3 (1:500,
eBioscience, San Diego, CA), mouse anti-Nestin-Alexa Fluor 647
(1:20, Clone: 25/Nestin, BD Pharmingen, San Jose, CA), mouse
anti-Tubulin-b-III-NorthernLights 637 (1:20, Clone: TuJ-1, R&D
Systems, Minneapolis, MN), mouse anti-GFAP-Alexa Fluor 488
(1:50, Clone: 131-15019, Invitrogen, Carlsbad, CA), mouse anti-
oligodendrocyte marker O4-PE (10ml, Clone: O4, R&D Systems),
goat anti-mouse Patched (1:20, R&D Systems), Rat anti-Gli1-
FITC (1:100, R&D Systems), rabbit anti-mouse Phospho-MEK1/
2 (1:100, Cell Signaling Technology, Danvers, MA), rabbit anti-
mouse Phospho-ERK (1:100, Cell Signaling Technology), and
hamster anti-mouse CD95-FITC (1:100, Clone: Jo2, BD Phar-
mingen). Secondary antibodies included donkey anti-mouse-APC,
donkey anti-goat-PE, donkey anti-mouse-FITC, donkey anti rat-
FITC, (1:1000, Jackson Immunoresearch, West Grove, MA), goat
anti-rat-PE (1:100, R&D Systems), and goat anti-rabbit-APC
(1:100, R&D Systems). Flow cytometry isotype controls were PE
rat IgG2a k, FITC rat IgG2a k, APC mouse IgG2a k, FITC
mouse IgG1 k, and APC mouse IgG1 k isotype (BD Biosciences,
Bedford, MA).
Flow cytometry
BrdU was added to cortical neurosphere cultures at 10 mM,
12 hours prior to culture processing. Neurospheres were pelleted
by centrifugation at 800 xg for 5 minutes. Cell pellets were then
suspended in 2 ml of trypLE stable trypsin replacement enzyme
(Invitrogen, San Diego, CA) and incubated at 37uC for 15
minutes. The neurosphere suspensions were pelleted again and
resuspended in 2 ml of NeuroCult NSC proliferation media
supplemented with 250 U/ml of DNAse I (Sigma-Aldrich, Saint
Louis, MO, USA). Single cell suspensions were obtained by
trituration with fire-polished glass Pasteur pipettes. Intracellular
BrdU was measured using the BrdU Flow Kit (BD Biosciences,
Bedford, MA). Cells were resuspended in 50 ml of staining buffer
(PBS with 1.0% FBS). Cells were fixed, permeabilized, and treated
with DNAse (30 mg per tube) to expose incorporated BrdU. Cells
were resuspended in 50 ml of BD Perm/fix buffer containing anti-
BrdU-FITC antibodies (1:50) and relevant antibodies specific for
detection of intracellular antigens, followed by staining with
secondary antibodies. Cells were washed and resuspended in
staining buffer and analyzed by multicolor flow cytometry on a
LSRII Analyzer (Becton Dickinson, Franklin Lakes, NJ). After
gating to exclude dead cells and debris based on forward and side
scatter, data were analyzed using FACS DiVa acquisition software
(Becton Dickinson, Franklin Lakes, NJ) and FlowJo6.1 (Tree Star,
Ashland, OR).
Apoptosis assays
Cell suspensions of cortical neurospheres were washed twice
with PBS, resuspended in 0.1 ml Annexin V binding buffer (BD
Biosciences), and incubated with 5 ml of FITC-conjugated
Annexin V (BD Biosciences) and 10 ml of propidium iodide (PI)
for 15 min at room temperature. Cells were immediately analyzed
by flow cytometry on a FACSCalibur (Becton Dickinson). Data
were obtained using CellQuest acquisition software (Becton
Dickinson) and analyzed using FlowJo6.1 (Tree Star, Ashland,
OR, USA). Cells stained with Annexin V-FITC alone and PI
alone were used as controls.
Statistical analysis
StatView version 5.0.1 software (Windows version; SAS
Institute, Cary, NC, USA) was used for all statistical analyses.
Mann–Whitney U-tests (independent variable: dose group) were
used for group comparisons requiring nonparametric analytic
approaches. For all tests, statistical significance was assumed where
p,0.05.
Supporting Information
Figure S1 Phase contrast images of primary neuro-
sphere cultures. EGF-responsive murine cortical cells, isolated
from GD 14 WT embryo, were grown for 1 day or for 7 days in
proliferation medium supplemented with 20 ng/ml of EGF. (a)
Small clusters of cells were visible one day after plating. (b)
Spherical, bright phase and viable neurospheres were identified
after 7 days in vitro. Magnification, 10X.
(TIF)
Figure S2 Percentage of nestin-positive cells at different
passages. Cortical cells were obtained from WT embryos at
GD14 and cultured in EGF-containing proliferation medium
(20 ng/ml) for 7 days to form neurospheres. Cells were passaged
once a week by enzymatic and mechanical re-dissociation and re-
plated. (a) Representative histograms showing the percentages of
nestin
+cells in primary and (b) secondary neurospheres (2
nd
passage) that were in culture for 7 days. Numbers in gates
represent the percentages of nestin
+ cells. Three independent cell
culture assays were performed with cells isolated from embryos
(n=12); data from one representative assay is shown.
(TIF)
Figure S3 In vitro differentiation of WT neurospheres.
Dissociated cells from WT primary cortical neurospheres were
plated onto poly-D-lysine/laminin-coated six-well plates (Sigma)
and differentiated in serum-free DMEM/F-12 medium (Invitro-
gen) supplemented with B27 (Invitrogen), Neurocult NSC
supplement (Stem cell) and 1% Fetal calf serum (Invitrogen) for
7 days. (a–c) During differentiation, neurosphere-derived cells lost
their spherical shape and flattened to form a monolayer (bright
field, a). Immunofluorescence analysis showed that WT neuro-
spheres were multipotent and expressed genes such as bIII-tubulin
(red, b) or GFAP (red, c), markers characteristic for neurons and
astrocytes, respectively. WT neurospheres also expressed nestin
(green, b, c). Nuclear staining (blue, b, c). (d–f) Representative
histograms showing the percentages of differentiated WT neuro-
sphere-derived cells expressing tubulin-b-III (d), O4 (e), and GFAP
(f). Numbers in gates represent the percentages of each sub-
population. Overlays represent the mean fluorescence intensity
expressed as a percentage of the maximum expression: ——, cell
lineage marker; ——, isotype control.
(TIF)
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